Generic placeholder image

Current Pharmaceutical Design

Author(s): Mohit Kumar, Devesh Kumar, Sumant Kumar, Akshay Kumar and Uttam Kumar Mandal*

DOI: 10.2174/1381612829666221021152354

DownloadDownload PDF Flyer Cite As
A Recent Review on Bio-availability Enhancement of Poorly Water-soluble Drugs by using Bioenhancer and Nanoparticulate Drug Delivery System

Page: [3212 - 3224] Pages: 13

  • * (Excluding Mailing and Handling)

Abstract

Background: Intravenous route of drug administration has maximum bioavailability, which shows 100% of the drug reaches blood circulation, whereas the oral administration of drugs, are readily undergoing pre-systemic metabolism, which means the poor bioavailability of the drug and limited amount of drug reaches the target site.

Introduction: Bioenhancers are substances having medicinal entities which enhance the bioavailability and efficacy of the active constituents of drugs. The enhanced bioavailability of drugs may lead to dose reduction, which may further reduce the cost and undesired side effects associated with the drugs.

Methods: The solid lipid nanoparticles (SLNs) loaded with ketoprofen made from carnauba wax and beeswax. It was discovered that when the drug-loaded SLNs were mixed with egg-lecithin and Tween-80, as well as when the total surfactant concentration was increased, the average particle size of the drug-loaded SLNs decreased.

Results: The drug-loaded nanoparticles, when given in combination with bio-enhancers such as piperine and quercetin, enhanced the drug's effectiveness. The Area Under Curve (AUC) was increased when the drug was coupled with bio-enhancers. Based on the findings, it can be concluded that piperine and quercetin when used with drug-loaded nanoparticles improve their therapeutic effectiveness.

Conclusion: Bioenhancers are crucial to amplifying the bioavailability of many synthetic drugs. These attributes are useful to reduce the dose of drugs and increase the therapeutic efficacy of drugs with poor bioavailability.

[1]
Atal N, Bedi KL. Bioenhancers: Revolutionary concept to market. J Ayurveda Integr Med 2010; 1(2): 96-9.
[http://dx.doi.org/10.4103/0975-9476.65073] [PMID: 21836795]
[2]
Schulz V, Hänsel R, Tyler VE. Rational phytotherapy: A physician’s guide to herbal medicine Psychology Press Ber-lin. Springer 2001.
[http://dx.doi.org/10.1007/978-3-642-98093-0]
[3]
Ghosh D. Seed to Patient in Clinically Proven Natural Medi-cines. Nutraceuticals. Elsevier Amsterdam 2016; pp. 925-31.
[http://dx.doi.org/10.1016/B978-0-12-802147-7.00064-4]
[4]
Organization WH. Informal Meeting on Strategic Directions for Traditional Medicine in the Western Pacific Region, Ma-nila, Philippines, 4-5 May 2010: Report. Manila: WHO Re-gional Office for the Western Pacific 2010.
[5]
Ernst E. Herbal medicines–they are popular, but are they also safe? Eur J Clin Pharmacol 2006; 62: 1-2.
[http://dx.doi.org/10.1007/s00228-005-0070-2]
[6]
Keller K. Herbal medicinal products in Germany and Europe: Experiences with national and European assessment. Drug Inf J 1996; 30(4): 933-48.
[http://dx.doi.org/10.1177/009286159603000409]
[7]
Friel H, Frautschy SA. A paradigm shift to prevent and treat Alzheimer’s disease: From monotargeting pharmaceuticals to pleiotropic plant polyphenols. Academic Press: Amsterdam 2017.
[8]
Sharma P, Pham H, Zargar-Shoshtari K. Management of urologic disorders and the pharmacist’s role: Benign prostatic hyperplasia. 2019.
[9]
Patil UK, Singh A, Chakraborty AK. Role of piperine as a bioavailability enhancer. Int J Recent Adv Pharm Res 2011; 4: 16-23.
[10]
Dudhatra GB, Mody SK, Awale MM, et al. A comprehensive review on pharmacotherapeutics of herbal bioenhancers. Sci World J 2012; 2012
[http://dx.doi.org/10.1100/2012/637953]
[11]
Tatiraju DV, Bagade VB, Karambelkar PJ, Jadhav VM, Ka-dam V. Natural bioenhancers: An overview. J Pharmacogn Phytochem 2013; 2(3): 55-60.
[12]
Ratndeep S, Sarita D, Patel JH, et al. Indian herbal bioen-hancers: A review. Pharmacogn Rev 2009; 3(5): 80-2.
[13]
Brahmankar DM, Jaiswal SB. Biopharmaceutics and pharma-cokinetics-A Treatise Vallabh Prakashan. New Delhi 1995.
[14]
Savjani KT, Gajjar AK, Savjani JK. Drug solubility: Im-portance and enhancement techniques. Int Sch Res Not 2012; 2012.
[15]
Kesarwani K, Gupta R, Mukerjee A. Bioavailability enhanc-ers of herbal origin: An overview. Asian Pac J Trop Biomed 2013; 3(4): 253-66.
[http://dx.doi.org/10.1016/S2221-1691(13)60060-X] [PMID: 23620848]
[16]
Mekala P, Arivuchelvan A. Bioenhancer for animal health and production. A Review 2012.
[17]
Db MSS, Kr M. Role of piperine as an effective bioenhanc-er in drug absorption. Pharm Anal Acta 2018; 9(7): 1-4.
[http://dx.doi.org/10.4172/2153-2435.1000591]
[18]
Hunter J, Hirst BH. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Adv Drug Deliv Rev 1997; 25(2-3): 129-57.
[http://dx.doi.org/10.1016/S0169-409X(97)00497-3] [PMID: 10837555]
[19]
Holm R, Müllertz A, Mu H. Bile salts and their importance for drug absorption. Int J Pharm 2013; 453(1): 44-55.
[http://dx.doi.org/10.1016/j.ijpharm.2013.04.003] [PMID: 23598075]
[20]
Balakrishnan V, Varma S, Chatterji D. Piperine augments transcription inhibitory activity of rifampicin by severalfold in Mycobacterium smegmatis. Curr Sci 2001; 1302-5.
[21]
Tiwari A, Mahadik KR, Gabhe SY. Piperine: A comprehen-sive review of methods of isolation, purification, and biolog-ical properties. Medicine in Drug Discovery 2020; 7: 100027.
[http://dx.doi.org/10.1016/j.medidd.2020.100027]
[22]
Nijveldt RJ, van Nood E, van Hoorn DEC, Boelens PG, van Norren K, van Leeuwen PAM. Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001; 74(4): 418-25.
[http://dx.doi.org/10.1093/ajcn/74.4.418] [PMID: 11566638]
[23]
Kale A, Gawande S, Kotwal S, et al. Studies on the effects of oral administration of nutrient mixture, quercetin and red on-ions on the bioavailability of epigallocatechin gallate from green tea extract. Phytother Res 2010; 24(S1) (Suppl. 1): S48-55.
[http://dx.doi.org/10.1002/ptr.2899] [PMID: 19585479]
[24]
Choi JS, Li X. Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits. Int J Pharm 2005; 297(1-2): 1-8.
[http://dx.doi.org/10.1016/j.ijpharm.2004.12.004] [PMID: 15907592]
[25]
Dupuy J, Larrieu G, Sutra JF, Lespine A, Alvinerie M. En-hancement of moxidectin bioavailability in lamb by a natural flavonoid: Quercetin. Vet Parasitol 2003; 112(4): 337-47.
[http://dx.doi.org/10.1016/S0304-4017(03)00008-6] [PMID: 12623212]
[26]
Miniscalco A, Lundahl J, Regårdh CG, Edgar B, Eriksson UG. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther 1992; 261(3): 1195-9.
[PMID: 1602384]
[27]
Scambia G, Ranelletti FO, Panici PB, et al. Quercetin potenti-ates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 1994; 34(6): 459-64.
[http://dx.doi.org/10.1007/BF00685655] [PMID: 7923555]
[28]
Zhang H, Wong CW, Coville PF, Wanwimolruk S. Effect of the grapefruit flavonoid naringin on pharmacokinetics of quinine in rats. Drug Metabol Drug Interact 2000; 17(1-4): 351-63.
[http://dx.doi.org/10.1515/DMDI.2000.17.1-4.351] [PMID: 11201303]
[29]
Zhang W, Tan TMC, Lim LY. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab Dispos 2007; 35(1): 110-5.
[http://dx.doi.org/10.1124/dmd.106.011072] [PMID: 17050652]
[30]
Singh M, Varshneya C, Telang RS, Srivastava AK. Alteration of pharmacokinetics of oxytetracycline following oral admin-istration of Piper longum in hens. J Vet Sci 2005; 6(3): 197-200.
[http://dx.doi.org/10.4142/jvs.2005.6.3.197] [PMID: 16131821]
[31]
Basu NK, Kole L, Kubota S, Owens IS. Human UDP-glucuronosyltransferases show atypical metabolism of my-cophenolic acid and inhibition by curcumin. Drug Metab Dispos 2004; 32(7): 768-73.
[http://dx.doi.org/10.1124/dmd.32.7.768] [PMID: 15205394]
[32]
Khanuja SPS, Arya JS, Tiruppadiripuliyur RSK, et al. Nitrile glycoside useful as a bioenhancer of drugs and nutrients, process of its isolation from Moringa oleifera. In: Google Patents. 2005.
[33]
Pal A, Bawankule DU, Darokar MP, et al. Influence of Moringa oleifera on pharmacokinetic disposition of rifampic-in using HPLC-PDA method: A pre-clinical study. Biomed Chromatogr 2011; 25(6): 641-5.
[http://dx.doi.org/10.1002/bmc.1494] [PMID: 20845375]
[34]
Vinson JA, Al Kharrat H, Andreoli L. Effect of Aloe vera preparations on the human bioavailability of vitamins C and E. Phytomedicine 2005; 12(10): 760-5.
[http://dx.doi.org/10.1016/j.phymed.2003.12.013] [PMID: 16323295]
[35]
Kurzer MS, Xu X. Dietary phytoestrogens. Annu Rev Nutr 1997; 17(1): 353-81.
[http://dx.doi.org/10.1146/annurev.nutr.17.1.353] [PMID: 9240932]
[36]
Sparreboom A, van Asperen J, Mayer U, et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA 1997; 94(5): 2031-5.
[http://dx.doi.org/10.1073/pnas.94.5.2031] [PMID: 9050899]
[37]
Sumano-López H, Gutiérrez-Olvera L, Aguilera-Jiménez R, Gutiérrez-Olvera C, Jiménez-Gómez F. Administration of ciprofloxacin and capsaicin in rats to achieve higher maximal serum concentrations. Arzneimittelforschung 2007; 57(5): 286-90.
[PMID: 17598701]
[38]
Bouraoui A, Toumi A, Ben Mustapha H, Brazier JL. Effects of capsicum fruit on theophylline absorption and bioavaila-bility in rabbits. Drug Nutr Interact 1988; 5(4): 345-50.
[PMID: 3240714]
[39]
Nishanth BC. SV PK, Kamal D, Sandeep M, Megharaj HK. Cow urine concentrate: A potent agent with antimicrobial and anthelmintic activity. J Pharm Res 2010; 3(5): 1025-7.
[40]
Khan A, Srivastava VK. Antitoxic and bioenhancing role of kamdhenu ark (cow urine distillate) on fertilitty rate of male mice (Mus musculus) affected by cadmium chloride toxicity. Int J Cow Sci 2005; 1(2): 43-6.
[41]
Ganaie JA, Shrivastava VK. Effects of gonadotropin releas-ing hormone conjugate immunization and bioenhancing role of Kamdhenu ark on estrous cycle, serum estradiol and pro-gesterone levels in female Mus musculus 2010.
[42]
Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta Biomembr 1976; 455(1): 152-62.
[http://dx.doi.org/10.1016/0005-2736(76)90160-7] [PMID: 990323]
[43]
Yokokawa M, Nishigaki R, Umemura K, Hayton WL. Intes-tinal absorption kinetics using a laminar flow model. J Pharmacobiodyn 1989; 12(6): 332-40.
[http://dx.doi.org/10.1248/bpb1978.12.332] [PMID: 2778626]
[44]
Schinkel AH, Jonker JW. Mammalian drug efflux transport-ers of the ATP binding cassette (ABC) family: An overview. Adv Drug Deliv Rev 2012; 64: 138-53.
[http://dx.doi.org/10.1016/j.addr.2012.09.027] [PMID: 12535572]
[45]
Kang MJ, Cho JY, Shim BH, Kim DK, Lee J. Bioavailability enhancing activities of natural compounds from medicinal plants. J Med Plants Res 2009; 3(13): 1204-11.
[46]
Gade J, Jain B, Rawat R, Prashant Sharma P, Gupta P. An effective nanoparticles for drug delivery system. Mater Today Proc 2022; 51: A1-7.
[http://dx.doi.org/10.1016/j.matpr.2021.05.407]
[47]
Gade JV, Prashant Sharma P, Jain B, Rawat R. Synthesis and characterization of paclitaxel nanoparticles for drug delivery. Mater Today Proc 2022; 51: 445-50.
[http://dx.doi.org/10.1016/j.matpr.2021.05.573]
[48]
Dogra A, Gour A, Bhatt S, et al. Effect of rutin on pharma-cokinetic modulation of diclofenac in rats. Xenobiotica 2020; 50(11): 1332-40.
[http://dx.doi.org/10.1080/00498254.2020.1773008] [PMID: 32432967]
[49]
Dogra A, Bhatt S, Magotra A, et al. Intervention of curcumin on oral pharmacokinetics of daclatasvir in rat: A possible risk for long-term use. Phytother Res 2018; 32(10): 1967-74.
[http://dx.doi.org/10.1002/ptr.6123] [PMID: 29806225]
[50]
Jin ZH, Qiu W, Liu H, Jiang XH, Wang L. Enhancement of oral bioavailability and immune response of Ginsenoside Rh2 by co-administration with piperine. Chin J Nat Med 2018; 16(2): 143-9.
[http://dx.doi.org/10.1016/S1875-5364(18)30041-4] [PMID: 29455730]
[51]
Bi X, Yuan Z, Qu B, Zhou H, Liu Z, Xie Y. Piperine enhanc-es the bioavailability of silybin via inhibition of efflux trans-porters BCRP and MRP2. Phytomedicine 2019; 54: 98-108.
[http://dx.doi.org/10.1016/j.phymed.2018.09.217] [PMID: 30668388]
[52]
Sharma A, Magotra A, Bhatt S, et al. Potential herb-drug interaction of a flavone glycoside from Cuminum cyminum: Possible pathway for bioenhancement of rifampicin. 2018.
[53]
Prasad R, Singh A, Gupta N, Tarke C. Role of bioenhancers in tuberculosis. Int J Heal Sci Res 2016; p. 3076.
[54]
Di X, Wang X, Di X, Liu Y. Effect of piperine on the bioa-vailability and pharmacokinetics of emodin in rats. J Pharm Biomed Anal 2015; 115: 144-9.
[http://dx.doi.org/10.1016/j.jpba.2015.06.027] [PMID: 26201645]
[55]
Johnson JJ, Nihal M, Siddiqui IA, et al. Enhancing the bioa-vailability of resveratrol by combining it with piperine. Mol Nutr Food Res 2011; 55(8): 1169-76.
[http://dx.doi.org/10.1002/mnfr.201100117] [PMID: 21714124]
[56]
Vijayan UK, Varakumar S, Sole S, Singhal RS. Enhancement of loading and oral bioavailability of curcumin loaded self-microemulsifying lipid carriers using Curcuma oleoresins. Drug Dev Ind Pharm 2020; 46(6): 889-98.
[http://dx.doi.org/10.1080/03639045.2020.1762201] [PMID: 32340496]
[57]
Islam N, Irfan M, Hussain T, et al. Piperine phytosomes for bioavailability enhancement of domperidone. J Liposome Res 2022; 32(2): 172-80.
[http://dx.doi.org/10.1080/08982104.2021.1918153] [PMID: 33944662]
[58]
Suresh A, Narayan R, Tummala HP, et al. Enhancing the oral bioavailability of asenapine maleate with bio-enhancer: An in-silico assisted in-vivo pharmacokinetic study. J Drug Deliv Sci Technol 2022; 70: 103215.
[http://dx.doi.org/10.1016/j.jddst.2022.103215]
[59]
Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003; 8(24): 1112-20.
[http://dx.doi.org/10.1016/S1359-6446(03)02903-9] [PMID: 14678737]
[60]
Allen TM. Liposomes. Opportunities in drug delivery. Drugs 1997; 54(4) (Suppl. 4): 8-14.
[http://dx.doi.org/10.2165/00003495-199700544-00004] [PMID: 9361956]
[61]
Prajapati VD, Jani GK, Kapadia JR. Current knowledge on biodegradable microspheres in drug delivery. Expert Opin Drug Deliv 2015; 12(8): 1283-99.
[http://dx.doi.org/10.1517/17425247.2015.1015985] [PMID: 25687105]
[62]
Ajazuddin Saraf. Applications of novel drug delivery system for herbal formulations. Fitoterapia 2010; 81(7): 680-9.
[http://dx.doi.org/10.1016/j.fitote.2010.05.001] [PMID: 20471457]
[63]
Sun P, Den SH, Yu WP. Evaluation of garlicin liposomes. J Shan Univ TCM 2007; 31(1): 37-9.
[64]
Elsamaligy M, Afifi N, Mahmoud E. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stabil-ity and in vivo performance. Int J Pharm 2006; 319(1-2): 121-9.
[http://dx.doi.org/10.1016/j.ijpharm.2006.04.023] [PMID: 16837151]
[65]
He Z-F, Liu D-Y, Zeng S, Ye J-T. Study on preparation of ampelopsin liposomes. Zhongguo Zhongyao Zazhi 2008; 33(1): 27-30.
[PMID: 18338614]
[66]
Hong W, Chen D-W, Zhao X-L, Qiao M-X, Hu H-Y. Prepara-tion and study in vitro of long-circulating nanoliposomes of curcumin. Zhongguo Zhongyao Zazhi 2008; 33(8): 889-92.
[PMID: 18619344]
[67]
Rane S, Prabhakar B. Influence of liposome composition on paclitaxel entrapment and pH sensitivity of liposomes. Int J Pharm Tech Res 2009; 1(3): 914-7.
[68]
Chao P, Deshmukh M, Kutscher HL, et al. Pulmonary target-ing microparticulate camptothecin delivery system: Anti-cancer evaluation in a rat orthotopic lung cancer model. Anticancer Drugs 2010; 21(1): 65-76.
[http://dx.doi.org/10.1097/CAD.0b013e328332a322] [PMID: 19966540]
[69]
Xio L, Zang YH, Jin XH. Preparation of floating rutin aligi-nate chitosan microsphere. Chinese Tradit Herb drugs 2008; 3: 209-12.
[70]
Machida Y, Onishi H, Kurita A, Hata H, Morikawa A, Machida Y. Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats. J Control Release 2000; 66(2-3): 159-75.
[http://dx.doi.org/10.1016/S0168-3659(99)00267-9] [PMID: 10742577]
[71]
You J, Cui F, Han X, et al. Study of the preparation of sus-tained-release microspheres containing zedoary turmeric oil by the emulsion–solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil. Colloids Surf B Biointerfaces 2006; 48(1): 35-41.
[http://dx.doi.org/10.1016/j.colsurfb.2005.12.011] [PMID: 16480856]
[72]
Gavini E, Alamanni MC, Cossu M, Giunchedi P. Tabletted microspheres containing Cynara scolymus (var. Spinoso sar-do) extract for the preparation of controlled release nutraceu-tical matrices. J Microencapsul 2005; 22(5): 487-99.
[http://dx.doi.org/10.1080/02652040500099919] [PMID: 16361192]
[73]
Majuru S, Oyewumi MO. Nanotechnology in drug develop-ment and life cycle management. In: Nanotechnology in drug delivery. Springer: New York 2009; pp. 597-619.
[http://dx.doi.org/10.1007/978-0-387-77668-2_20]
[74]
Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002; 54 (Suppl. 1): S131-55.
[http://dx.doi.org/10.1016/S0169-409X(02)00118-7] [PMID: 12460720]
[75]
Walve JR, Bakliwal SR, Rane BR, Pawar SP. Transfersomes: A surrogated carrier for transdermal drug delivery system 2011.
[76]
Nayak BS, Ramdeen R, Adogwa A, Ramsubhag A, Marshall JR. Wound-healing potential of an ethanol extract of Carica papaya (Caricaceae) seeds. Int Wound J 2012; 9(6): 650-5.
[http://dx.doi.org/10.1111/j.1742-481X.2011.00933.x] [PMID: 22296524]
[77]
Sachan R, Parashar T, Soniya SV, et al. Drug carrier transfer-somes: A novel tool for transdermal drug delivery system. Int J Res Dev Pharm Life Sci 2013; 2(2): 309-16.
[78]
Mei Z, Chen H, Weng T, Yang Y, Yang X. Solid lipid nano-particle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 2003; 56(2): 189-96.
[http://dx.doi.org/10.1016/S0939-6411(03)00067-5] [PMID: 12957632]
[79]
Feng-Lin Y, Tzu-Hui W, Liang-Tzung L, Thau-Ming C, Chun-Ching L. Preparation and characterization of Cuscuta chinensis nanoparticles. Food Chem Toxicol 2008; 46: 1771-7.
[80]
Yen FL, Wu TH, Lin LT, Cham TM, Lin CC. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure. Pharm Res 2009; 26(4): 893-902.
[http://dx.doi.org/10.1007/s11095-008-9791-0] [PMID: 19034626]
[81]
Su YL, Fu ZY, Zhang JY, et al. Microencapsulation of Radix salvia miltiorrhiza nanoparticles by spray-drying. Powder Technol 2008; 184(1): 114-21.
[http://dx.doi.org/10.1016/j.powtec.2007.08.014]
[82]
Fu RQ, He FC, Meng DS, Chen L. Preparation of paclitaxelloaded poly (d, l-lactic acid) nanoparticles. ACTA Acad Med Mil tertiae 2006; 28: 1573-4.
[83]
Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Enhanced therapeutic potential of naringenin-phospholipid complex in rats. J Pharm Pharmacol 2010; 58(9): 1227-33.
[http://dx.doi.org/10.1211/jpp.58.9.0009] [PMID: 16945181]
[84]
Bhattacharya S. Phytosomes: The new technology for en-hancement of bioavailability of botanicals and nutraceuticals. International Journal of Health Research 2009; 2(3): 225-32.
[http://dx.doi.org/10.4314/ijhr.v2i3.47905]
[85]
Yanyu X, Yunmei S, Zhipeng C, Qineng P. The preparation of silybin–phospholipid complex and the study on its phar-macokinetics in rats. Int J Pharm 2006; 307(1): 77-82.
[http://dx.doi.org/10.1016/j.ijpharm.2005.10.001] [PMID: 16300915]
[86]
Panda VS, Naik SR. Cardioprotective activity of Ginkgo bi-loba Phytosomes in isoproterenol-induced myocardial ne-crosis in rats: A biochemical and histoarchitectural evalua-tion. Exp Toxicol Pathol 2008; 60(4-5): 397-404.
[http://dx.doi.org/10.1016/j.etp.2008.03.010] [PMID: 18513933]
[87]
Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007; 330(1-2): 155-63.
[http://dx.doi.org/10.1016/j.ijpharm.2006.09.025] [PMID: 17112692]
[88]
Xiao-Ying L, Luo J-B, Yan Z-H, Rong H-S, Huang W-M. Preparation and in vitro and in vivo evaluations of topically applied capsaicin transfersomes. Yao Xue Xue Bao 2006; 41(5): 461-6.
[PMID: 16848325]
[89]
Singh HP, Utreja P, Tiwary AK, Jain S. Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity. AAPS J 2009; 11(1): 54-64.
[http://dx.doi.org/10.1208/s12248-008-9078-8] [PMID: 19191031]
[90]
Zheng Y, Hou SX, Chen T, Lu Y. Preparation and characteri-zation of transfersomes of three drugs in vitro. Zhongguo Zhongyao Zazhi 2006; 31(9): 728-31.
[PMID: 17048677]
[91]
Zhaowu Z, Xiaoli W, Yangde Z, Nianfeng L. Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats. J Liposome Res 2009; 19(2): 155-62.
[http://dx.doi.org/10.1080/08982100902722381] [PMID: 19241204]
[92]
Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release 2005; 106(1-2): 99-110.
[http://dx.doi.org/10.1016/j.jconrel.2005.04.007] [PMID: 15935505]
[93]
Cote B, Elbarbry F, Bui F, et al. Mechanistic basis for the role of phytochemicals in inflammation-associated chronic diseases. Molecules 2022; 27(3): 781.
[http://dx.doi.org/10.3390/molecules27030781] [PMID: 35164043]
[94]
Sharma MK, Nagar D. Development of botanicals to combat antibiotic resistance. World J Pharm Res 2021; 10(3): 962-96.
[95]
Singh A, Verma BK, Pandey S. Exploring natural bioenhanc-ers to enhancing bioavailability: An Overview. Int J Pharm Life Sci 2021; 12(2)
[96]
Agrawal S, Gurjar P, Agarwal A. Herbal bioenhancers in microparticulate drug delivery. In: Drug Deliv Technol Herb Bioenhancers Pharm. 2022; p. 27.
[97]
Moragrega I, Ríos JL. Medicinal plants in the treatment of depression: Evidence from preclinical studies. Planta Med 2021; 87(9): 656-85.
[http://dx.doi.org/10.1055/a-1338-1011] [PMID: 33434941]
[98]
Lamanna-Rama N, Romero-Miguel D, Desco M, Soto-Montenegro ML. An update on the exploratory use of cur-cumin in neuropsychiatric disorders. Antioxidants 2022; 11(2): 353.
[http://dx.doi.org/10.3390/antiox11020353] [PMID: 35204235]
[99]
Patil RA, Pardeshi KH, Chavan HP, Amrutkar SV. Pharma-cotherapeutics and pharmacokinetics of herbal bioenhancers. Drug Deliv Technol Herb Bioenhancers Pharm. 2022; p. 149.
[100]
Kamiloglu S, Tomas M, Ozdal T, Capanoglu E. Effect of food matrix on the content and bioavailability of flavonoids. Trends Food Sci Technol 2021; 117: 15-33.
[http://dx.doi.org/10.1016/j.tifs.2020.10.030]
[101]
Patil R, Aher P, Bagad P, Ekhande S. Herbal bioenhancers in veterinary phytomedicine. In: Drug Deliv Technol Herb Bioen-hancers Pharm. 2022; p. 325.
[102]
Jampilek J, Kralova K. Advances in nanostructures for anti-microbial therapy. Materials (Basel) 2022; 15(7): 2388.
[http://dx.doi.org/10.3390/ma15072388] [PMID: 35407720]
[103]
Sahu D, Thakur A, Sahu G, et al. Studies on the effect of herbal bioenhancers on wound healing activity of simvastatin in rats 2022.
[104]
Liu Y, Yang F, Zhao X, Wang S, Yang Q, Zhang X. Crystal structure, solubility, and pharmacokinetic study on a hes-peretin cocrystal with piperine as coformer. Pharmaceutics 2022; 14(1): 94.
[http://dx.doi.org/10.3390/pharmaceutics14010094] [PMID: 35056990]
[105]
Kumar V, Chaudhary H, Kamboj A. Development and evalu-ation of isradipine via rutin-loaded coated solid–lipid nano-particles. Interv Med Appl Sci 2018; 10(4): 236-46.
[http://dx.doi.org/10.1556/1646.10.2018.45] [PMID: 30792921]
[106]
Gorle A. Gadgoli Chhaya Evaluation of hypoglycaemic activity of polyherbal formulation developed with bioenhancer 2018.